Review



serum il 34 levels  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech serum il 34 levels
    Serum Il 34 Levels, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/serum+il+34+levels/pm34217885-55-0-8?v=Proteintech
    Average 93 stars, based on 7 article reviews
    serum il 34 levels - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    93
    Proteintech serum il 34 levels
    Serum Il 34 Levels, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/serum+il+34+levels/pm34217885-55-0-8?v=Proteintech
    Average 93 stars, based on 1 article reviews
    serum il 34 levels - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    R&D Systems serum il‐34 levels
    Protein expression of <t>IL‐34</t> from human PTC samples. A, Western blot analysis of IL‐34 expression in PTC tissues, their adjacent noncancerous tissues, and normal controls. B, The ratio of IL‐34/GAPDH was determined to give a mean net density. C, Real‐time PCR analysis of IL‐34 expression in PTC tissues, their adjacent noncancerous tissues, and normal controls. Data were presented as the means ± standard error. ** P < .01 was considered significant
    Serum Il‐34 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/serum+il+34+levels/pmc07439428-58-0-8?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    serum il‐34 levels - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Protein expression of IL‐34 from human PTC samples. A, Western blot analysis of IL‐34 expression in PTC tissues, their adjacent noncancerous tissues, and normal controls. B, The ratio of IL‐34/GAPDH was determined to give a mean net density. C, Real‐time PCR analysis of IL‐34 expression in PTC tissues, their adjacent noncancerous tissues, and normal controls. Data were presented as the means ± standard error. ** P < .01 was considered significant

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

    doi: 10.1002/jcla.23335

    Figure Lengend Snippet: Protein expression of IL‐34 from human PTC samples. A, Western blot analysis of IL‐34 expression in PTC tissues, their adjacent noncancerous tissues, and normal controls. B, The ratio of IL‐34/GAPDH was determined to give a mean net density. C, Real‐time PCR analysis of IL‐34 expression in PTC tissues, their adjacent noncancerous tissues, and normal controls. Data were presented as the means ± standard error. ** P < .01 was considered significant

    Article Snippet: Serum IL‐34 levels were analyzed by ELISA assay (R&D Systems, Minneapolis, MN, USA).

    Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction

    IL‐34 promotes proliferation on PTC cells. Cell proliferation was determined via the CCK‐8 assay to examine the proliferation of TPC‐1 (A) and K1 cells (B) in accordance to transfected with si‐NC or si‐IL‐34. Cell proliferation in TPC‐1 (C) and K1 cells (D) which were infected with lenti‐vector or lenti‐IL‐34. Data were presented as the means ± standard error. ** P < .01 was considered significant

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

    doi: 10.1002/jcla.23335

    Figure Lengend Snippet: IL‐34 promotes proliferation on PTC cells. Cell proliferation was determined via the CCK‐8 assay to examine the proliferation of TPC‐1 (A) and K1 cells (B) in accordance to transfected with si‐NC or si‐IL‐34. Cell proliferation in TPC‐1 (C) and K1 cells (D) which were infected with lenti‐vector or lenti‐IL‐34. Data were presented as the means ± standard error. ** P < .01 was considered significant

    Article Snippet: Serum IL‐34 levels were analyzed by ELISA assay (R&D Systems, Minneapolis, MN, USA).

    Techniques: CCK-8 Assay, Transfection, Infection, Plasmid Preparation

    IL‐34 inhibits apoptotic rates on PTC cells. Cell apoptosis was determined by flow cytometry after transfected with si‐IL‐34 or si‐NC in TPC‐1 (A) and K1 cells (B). Cell apoptosis in TPC‐1 (C) and K1 cells (D) which were infected with lenti‐vector or lenti‐IL‐34. The apoptotic rates were shown. Data were presented as the means ± standard error. ** P < .01 was considered significant

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

    doi: 10.1002/jcla.23335

    Figure Lengend Snippet: IL‐34 inhibits apoptotic rates on PTC cells. Cell apoptosis was determined by flow cytometry after transfected with si‐IL‐34 or si‐NC in TPC‐1 (A) and K1 cells (B). Cell apoptosis in TPC‐1 (C) and K1 cells (D) which were infected with lenti‐vector or lenti‐IL‐34. The apoptotic rates were shown. Data were presented as the means ± standard error. ** P < .01 was considered significant

    Article Snippet: Serum IL‐34 levels were analyzed by ELISA assay (R&D Systems, Minneapolis, MN, USA).

    Techniques: Flow Cytometry, Transfection, Infection, Plasmid Preparation

    IL‐34 promotes the invasion via on PTC cells. Two PTC cell lines were not only transfected with si‐IL‐34 or si‐NC were also infected with lenti‐vector or lenti‐IL‐34 for 48 h. A, The protein expression levels of E‐cadherin, N‐cadherin, and Vimentin were measured by Western blotting in PTC cells. The ratios of EMT biomarkers when transfected with si‐IL‐34 or si‐NC were determined to give a mean net density in TPC‐1 (B) and K1 cells (C). The ratios of EMT biomarkers when infected with lenti‐vector or lenti‐IL‐34 were determined to give a mean net density in TPC‐1 (D) and K1 cells (E). Data were presented as the means ± standard error. ** P < .01 was considered significant

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

    doi: 10.1002/jcla.23335

    Figure Lengend Snippet: IL‐34 promotes the invasion via on PTC cells. Two PTC cell lines were not only transfected with si‐IL‐34 or si‐NC were also infected with lenti‐vector or lenti‐IL‐34 for 48 h. A, The protein expression levels of E‐cadherin, N‐cadherin, and Vimentin were measured by Western blotting in PTC cells. The ratios of EMT biomarkers when transfected with si‐IL‐34 or si‐NC were determined to give a mean net density in TPC‐1 (B) and K1 cells (C). The ratios of EMT biomarkers when infected with lenti‐vector or lenti‐IL‐34 were determined to give a mean net density in TPC‐1 (D) and K1 cells (E). Data were presented as the means ± standard error. ** P < .01 was considered significant

    Article Snippet: Serum IL‐34 levels were analyzed by ELISA assay (R&D Systems, Minneapolis, MN, USA).

    Techniques: Transfection, Infection, Plasmid Preparation, Expressing, Western Blot

    IL‐34 promotes the invasion and activates the ERK signaling pathway on PTC cells. Two PTC cell lines were transfected with si‐IL‐34 or si‐NC were also infected with lenti‐vector or lenti‐IL‐34 for 48 h. A, The protein expression levels of p‐ERK and ERK were measured by Western blotting in PTC cells. The ratios of ERK and p‐ERK when transfected with si‐IL‐34 or si‐NC were determined to give a mean net density in TPC‐1 (B) and K1 cells (C). The ratios of ERK and p‐ERK when infected with lenti‐vector or lenti‐IL‐34 were determined to give a mean net density inTPC‐1 (D) and K1 cells (E). Data were presented as the means ± standard error. ** P < .01 was considered significant

    Journal: Journal of Clinical Laboratory Analysis

    Article Title: IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

    doi: 10.1002/jcla.23335

    Figure Lengend Snippet: IL‐34 promotes the invasion and activates the ERK signaling pathway on PTC cells. Two PTC cell lines were transfected with si‐IL‐34 or si‐NC were also infected with lenti‐vector or lenti‐IL‐34 for 48 h. A, The protein expression levels of p‐ERK and ERK were measured by Western blotting in PTC cells. The ratios of ERK and p‐ERK when transfected with si‐IL‐34 or si‐NC were determined to give a mean net density in TPC‐1 (B) and K1 cells (C). The ratios of ERK and p‐ERK when infected with lenti‐vector or lenti‐IL‐34 were determined to give a mean net density inTPC‐1 (D) and K1 cells (E). Data were presented as the means ± standard error. ** P < .01 was considered significant

    Article Snippet: Serum IL‐34 levels were analyzed by ELISA assay (R&D Systems, Minneapolis, MN, USA).

    Techniques: Transfection, Infection, Plasmid Preparation, Expressing, Western Blot